Make better use of breast milk oligosaccharide potential industrial upgrading impetus

Our reporter Han Songyan

Breast milk is the ideal food for infants, and exclusive breastfeeding provides all the fluids, energy and nutrients an infant needs up to 6 months of age

The development of HMOs is affected by regulations, markets and technological innovations

The "Breast Milk Oligosaccharides: Function, Regulatory Management and Application Prospect Report" (hereinafter referred to as the "Report") compiled by the Institute of Nutrition and Health of the Chinese Nutrition Society was recently released.

It is reported that the average total level of HMOs in breast milk is between 4g/L and 22g/L, and some individuals can even exceed 30g/L

As biologically active substances in breast milk, the development of HMOs is affected by regulations, markets, and technological innovations

In developed countries, the HMOs market is maturing, thanks to the advancement of regulatory and regulatory processes across the country

In China, HMOs are managed as "nutrient fortifiers" in food additives

It is reported that 2'-FL, LNnT, 2'-FL/DFL, LNT, 3'-SL and 6'-SL products produced by DSM have recently obtained the approval of the Ministry of Agriculture and Rural Affairs of China for the production of the above-mentioned HMO varieties.

Industry-university-research collaboration to explore the path of HMOs industrialization

Nestlé recently announced its full-year results for 2021, with its annual report showing that sales of human milk oligosaccharide (HMO) products continued to grow strongly, reaching CHF 1.

It is foreseeable that under the dual stimulation of market competition and health needs, the development prospects of HMOs in the Chinese market are very broad

The first is to prudently and actively promote the approval of different components of HMOs

The second is to take HMOs as one of the research directions of breast milk in China, and strengthen source innovation and support

　　The third is to strengthen the clinical application research of functional evaluation to provide a scientific basis for the addition and use of HMOs

　　The fourth is the collaboration of production, education, research and application to explore research and industrialization paths that suit China's needs

　　Fifth, make overall use of domestic and international market resources

"China Food News" (03 edition on April 6, 2022)

　　(Editor-in-charge: Han Songyan)